top of page
Busy Office

Kendall Investor Relations Leadership

Kendall IR is an investor relations firm providing senior-level strategic and operational IR services to biotech companies. We are former biotech senior executives with decades of experience in R&D, corporate development, commercial operations, finance, and investor relations, serving fellow biotech executives.

We understand science, value creation, and how investors assess biotech investment opportunities. Our backgrounds, coupled with our relationships and credibility in the biotech investment community enable us to provide thoughtful, effective IR service that maximizes long term value.

Carlo.png

Carlo Tanzi, Ph.D.

Principal & Founder

Biogen 030723_Hencke headshot (2)_edited

Michael Hencke

Managing Director

Lauren.png

Lauren Stival Hopfer

Senior Vice President

Photo for Bios (2)_edited_edited_edited.

Kim Smith

Senior Advisor

Breidenbach_headshot_edited.jpg

Mark Breidenbach, Ph.D

Managing Director

Sarah E Headshot_edited_edited.jpg

Sarah Ellinwood, Ph.D.

Senior Vice President

RM_headshot_Jan2022 (2)_edited.jpg

Ron Moldaver

Vice President

Interested in a career with Kendall Investor Relations?
bottom of page